Cure My Disease

Don't miss your cure!

 Log in / Sign up

Cord blood transplant trial offers new hope for rare EBV diseases

NCT ID NCT07381738

Recruiting now Disease control Sponsor: Fudan University Source: ClinicalTrials.gov ↗

First seen Feb 02, 2026 · Last updated Apr 28, 2026 · Updated 8 times

Summary

This study tests whether a transplant of donated umbilical cord blood can help control Epstein-Barr virus (EBV)-related lymphoproliferative diseases, including chronic active EBV infection and EBV-associated lymphoma. About 80 people aged 14 to 80 will receive the transplant and be monitored for response and side effects. The goal is to manage the disease, not to cure it, as patients may need long-term follow-up and care.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EPSTEIN-BARR VIRUS-ASSOCIATED LYMPHOPROLIFERATIVE DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Huadong hospital, Fudan university

    RECRUITING

    Shanghai, Shanghai Municipality, 200040, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Huashan Hospital, Fudan University

    RECRUITING

    Shanghai, Shanghai Municipality, 200040, China

    Contact Phone: •••-•••-••••

Conditions

Explore the condition pages connected to this study.

CHRONIC ACTIVE EPSTEIN-BARR VIRUS INFECTION EBV ASSOCIATED LYMPHOMA EPSTEIN-BARR VIRUS-ASSOCIATED LYMPHOPROLIFERATIVE DISEASES UMBILICAL CORD BLOOD TRANSPLANT